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Background: Significant aortic regurgitation (AR) might occur after transcatheter aortic valve implantation (TAVI), but its determinants remain 
unclear.
Objectives: To shed light on the predictors of significant AR occurring after TAVI.
Methods & Results: This analysis is based on 437 patients enrolled in the prospective multicenter German aortic valve registry who underwent 
successful TAVI for severe aortic stenosis. The study population’s mean age was 80.8 years and men represented 47%, with a mean aortic valve 
area of 0.7±0.5 cm2 and a mean gradient of 49±18 mmHg. Overall, 378 patients (86.5%) received the CoreValve Revalving system and 59 patients 
(13.5%) received the Edwards SAPIEN valve. The occurrence of paravalvular AR was evaluated angiographically immediately after the device 
deployment and after removal of the catheter and guidewire. Significant AR was defined as AR ≥2/4. The population for this study was divided into: 
patients with significant AR (82 patients, 19%, Group I) and patients with no/mild AR (355 patients, 81%, Group II). In the whole cohort, after TAVI, 
paravalvular AR was absent in 30% of patients, graded I in 51%, II in 17%, and III in 2% . Predictors of significant AR are mentioned in the table.
Conclusions: The occurrence of significant AR after TAVI is related to preprocedural factors that are mainly anatomical. Appropriate preprocedural 
evaluation is necessary with careful screening of patients for the previous factors and choosing the appropriate device thereafter. 
Predictors of AR
Variable Group I (AR≥2) Group II (AR<2) p OR(95%-CI)
Preoperative AR 85.3 71.7 <0.01 0.44 (0,24-0,80)
Annulus diameter(mm) 23 (21-25) 24 (22-26) <0.05
Bicuspid AV 4.2% 1.2% 0.05 0.29 (0.08-1.09)
Severe AS (grade IV) 53.3% 31.7% <0.0001 0.4(0,26-0,64)
Angle between ascending aorta and LV 20 (15-40) 15 (15-20) <0.01
Pulmonary hypertension 70.5% 59.3% <0.05 0.61(0,38-0,99)
Procedural time (min) 81 (60-110) 70 (52-95) <0.05
Previous cardiac surgery 30.2% 20.5% <0.05 0.6(0,36-0,98)
